期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

十二指肠间质瘤8例临床分析

下载PDF
导出
摘要 胃肠道间质瘤（gastrointestinal stromal tumour，GIST）已被公认为一种明确的病种。随着分子研究的突破、概念的更新、以及分子靶向治疗药物如伊马替尼的进展，单纯手术治疗的模式已成为历史。GIST可发生于消化道各个部位，但原发于十二指肠的GIST很少。关于十二指肠间质瘤诊治，目前国内外尚无系列的研究报道。现将本院1999年4月至2007年4月收治的8例十二指肠间质瘤的临床资料，进行回顾性分析如下。
作者 张则伟 徐志远 郭剑民 周立新
机构地区 浙江省肿瘤医院
出处 《浙江创伤外科》 2008年第1期50-51,共2页 Zhejiang Journal of Traumatic Surgery
关键词 十二指肠间质瘤 临床分析 胃肠道间质瘤 靶向治疗药物 单纯手术治疗 GIST 伊马替尼 临床资料
分类号 R735.31 [医药卫生—肿瘤] R735 [医药卫生—肿瘤]
  • 相关文献

参考文献8

  • 1Flecther CD, Berman J J, Corless C, et al.Diagnosis of gastrointestinal stormal tumours: a consensus approach [J]. Hum Pathol, 2002, 33(5):459-465.
  • 2Langer C, Gunawan B, Schuler P, et al.Prognostic factors influencing surgical management and outcome of gastrointestinal stormal tumors [J]. Br J Surg. 2003, 90:332-339.
  • 3Crosby JA, Catton CN, Davis A, et al. Malignant gastrointestinal stormal tumors of the small Intestine: a review of 50 cases from a prospective database [J]. Ann Surg Oncol. 2001, 8:50-59.
  • 4DeMatteo RP. Levis JJ. Leung D, et al. Two hundred gastrointestinal stormal tumors: recurrence pattems and prognostic factors for survival [J]. Ann Surg, 2000, 231:51-58.
  • 5DeMatteo RP, Shah A. Fong Y, et al. Resuits of hepatic resection for sarcoma metastatic to liver [J]. Ann Surg, 2001,243;540-548.
  • 6Husted TL, Neff C, Thomas MJ, et al. Liver transplantation for primary or metastatic sarcoma to the liver [J]. Am J Transplant, 2006, 6:392-397.
  • 7Blanke CD, Demetri CD, Von Mehren M, et al. Long-term follow-up of a phase Ⅱ randomized trial in advanced gastrointestinal stromal tumor (GIST) patients treated with imatinib mesylate [J]. Abstract No: 9528, J Clin Oncol, 2006 ASCO Annual Meeting Proceedings Part Ⅰ. Vol 24,No.18S.
  • 8詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量：85

二级参考文献21

  • 1Mudan SS,Conlon KC,Woodruff J,et al.Salvage surgery in recurrent gastrointestinal sarcoma:prognostic factors to guide patient selection.Cancer,2000,88:66-74.
  • 2DeMatteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival.Ann Surg,2000,231:51-58.
  • 3Mocellin S,Mencarelli R,Foletto M,et al.Gastrointestinal stromal tumors:from a surgical to a molecular approach.Int J Cancer,2003,107:171-176.
  • 4Dematteo RP,Shah A,Fong Y,et al.Results of hepatic resection for sarcoma metastatic to liver.Ann Surg,2001,234:540-548.
  • 5Husted TL,Neff G,Thomas MJ,et al.Liver transplantation for primary or metastatic sarcoma to the liver.Am J Transplant,2006,6:392-397.
  • 6Blanke CD,Demetri GD,Von Mehren M,et al.kong-term follow-up of a phase Ⅱ randomized trial in advanced gastrointestinal stromal tumor (GIST) patients treated with imatinib mesylate.Abstract No:9528,J Clin Oncol,2006 ASCO Annual Meeting Proceedings Part Ⅰ.Vol 24,No.18S.
  • 7Perez EA,Livingstone AS,Franceschi D,et al.Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors.J Am Coll Surg,2006,202:623-629.
  • 8Goettsch WG,Bos SD,Broekveldt-Postma N,et al.Incidence of gastrointestinal stromal tumours is underestimated:results of a nation-wide study.Eur J Cancer,2005,41:2868-2872.
  • 9Miettinen M,Lasota J.Gastrointestinal stromal tumours-definition,clinical,histological,immunohistochemical,and molecular genetic features and differential diagnosis.Virchows Arch,2001,438:1-12.
  • 10Demetri GD,von Mehren M,Blanke CD,et al.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumours.N Engl J Med,2002,347:472-480.

共引文献84

浙江创伤外科
2008年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部